Axol Bioscience appoints Liam Taylor as Chief Executive Officer

Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease-relevant cell-based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam will guide the growth of the Company and will focus on maximizing the potential of the team, and its iPSC (induced pluripotent stem cell) technologies, products, and services.

Liam is a highly experienced senior executive with extensive knowledge of running commercial, operations, finance and innovation teams in the diagnostic, pharma and life science sector, both in the UK and US. Most recently he was CFO and then Managing Director of BBI Solutions, during which time the business’ annual revenues grew from £23M to over £52M, driven by organic growth and strategic acquisitions, which broadened the Company’s product and service offerings.

Dr. Jonathan Milner, Chairman, Axol Bioscience, said: “The Board is delighted to appoint Liam as Axol’s new CEO. His wealth of experience and comprehensive knowledge of the pharma and life science sector will be invaluable in unlocking the full potential of the Company.”

The progress achieved at Axol Bioscience in developing high quality and consistent iPSCs has been impressive, and I am excited to be joining at an exciting point in the Company’s development where we will be working to scale up operations to support the rapidly growing biotech and pharmaceutical markets, to support increases in efficiency within drug screening and discovery.”

Liam Taylor, CEO, Axol Bioscience

For further information about Axol Bioscience’s leadership team, please visit: https://www.axolbio.com/page/meet-the-team

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Axol Bioscience Ltd. (2020, August 27). Axol Bioscience appoints Liam Taylor as Chief Executive Officer. News-Medical. Retrieved on September 20, 2021 from https://www.news-medical.net/news/20200827/Axol-Bioscience-appoints-Liam-Taylor-as-Chief-Executive-Officer.aspx.

  • MLA

    Axol Bioscience Ltd. "Axol Bioscience appoints Liam Taylor as Chief Executive Officer". News-Medical. 20 September 2021. <https://www.news-medical.net/news/20200827/Axol-Bioscience-appoints-Liam-Taylor-as-Chief-Executive-Officer.aspx>.

  • Chicago

    Axol Bioscience Ltd. "Axol Bioscience appoints Liam Taylor as Chief Executive Officer". News-Medical. https://www.news-medical.net/news/20200827/Axol-Bioscience-appoints-Liam-Taylor-as-Chief-Executive-Officer.aspx. (accessed September 20, 2021).

  • Harvard

    Axol Bioscience Ltd. 2020. Axol Bioscience appoints Liam Taylor as Chief Executive Officer. News-Medical, viewed 20 September 2021, https://www.news-medical.net/news/20200827/Axol-Bioscience-appoints-Liam-Taylor-as-Chief-Executive-Officer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Axol Bioscience strengthens commercial leadership team with key appointments